Application of non-coding RNAs in early diagnosis of colorectal cancer

Abstract

Wang Pei, Cui Manli, Zhang Mingxin. Application of non-coding RNAs in early diagnosis of colorectal cancer[J]. Journal of International Oncology, 2021, 48(8): 502-506.

References38

[1]	王裴, 张明鑫, 张超, 等. 粪便DNA甲基化检测在结直肠癌早期诊断中的研究进展[J]. 现代肿瘤医学, 2015,23(6):874-880. DOI: 10.3969/j.issn.1672-4992.2015.06.42. doi:10.3969/j.issn.1672-4992.2015.06.42
[2]	Nikolaou S, Qiu S, Fiorentino F, et al. Systematic review of blood diagnostic markers in colorectal cancer[J]. Tech Coloproctol, 2018,22(7):481-498. DOI: 10.1007/s10151-018-1820-3. doi:10.1007/s10151-018-1820-3pmid:30022330
[3]	Slaby O. Non-coding RNAs as biomarkers for colorectal cancer scree-ning and early detection[J]. Adv Exp Med Biol, 2016,937:153-170. DOI: 10.1007/978-3-319-42059-2_8. doi:10.1007/978-3-319-42059-2_8
[4]	Toiyama Y, Okugawa Y, Tanaka K, et al. A panel of methylated microRNA biomarkers for identifying high-risk patients with ulcerative colitis-associated colorectal cancer[J]. Gastroenterology, 2017, 153(6): 1634-1646.e8. DOI: 10.1053/j.gastro.2017.08.037. doi:S0016-5085(17)36070-5pmid:28847750
[5]	Michael MZ, O'Connor SM, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia[J]. Mol Cancer Res, 2003,1(12):882-891. pmid:14573789
[6]	Karimi L, Mansoori B, Shanebandi D, et al. Function of microRNA-143 in different signal pathways in cancer: new insights into cancer therapy[J]. Biomed Pharmacother, 2017,91:121-131. DOI: 10.1016/j.Biopha.2017.04.060. doi:S0753-3322(17)30698-4pmid:28448866
[7]	Liu T, Liu D, Guan S, et al. Diagnostic role of circulating miR-21 in colorectal cancer: a update meta-analysis[J]. Ann Med, 2021,53(1):87-102. DOI: 10.1080/07853890.2020.1828617. doi:10.1080/07853890.2020.1828617
[8]	Sabry D, El-Deek SEM, Maher M, et al. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway[J]. Mol Cell Biochem, 2019,454(1-2):177-189. DOI: 10.1007/s11010-018-3462-1. doi:10.1007/s11010-018-3462-1pmid:30357530
[9]	Sheng WZ, Chen YS, Tu CT, et al. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer[J]. World J Gastroenterol, 2016,22(24):5532-5539. DOI: 10.3748/wjg.v22.i24.5532. doi:10.3748/wjg.v22.i24.5532
[10]	Imaoka H, Toiyama Y, Fujikawa H, et al. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colo-rectal cancer[J]. Ann Oncol, 2016,27(10):1879-1886. DOI: 10.1093/annonc/mdw279. doi:10.1093/annonc/mdw279pmid:27502702
[11]	赵高传, 陈卿奇, 庞莉, 等. miR-205及miR-221在结肠癌患者血清中的水平及其临床意义[J]. 国际肿瘤学杂志, 2019,46(9):526-530. DOI: 10.3760/cma.j.issn.1673-422X.2019.09.003. doi:10.3760/cma.j.issn.1673-422X.2019.09.003
[12]	Zhu M, Huang Z, Zhu D, et al. A panel of microRNA signature in serum for colorectal cancer diagnosis[J]. Oncotarget, 2017,8(10):17081-17091. DOI: 10.18632/oncotarget.15059. doi:10.18632/oncotarget.15059
[13]	Kanaan Z, Roberts H, Eichenberger MR, et al. A plasma micro-RNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer[J]. Ann Surgery, 2013,258(3):400-408. DOI: 10.1097/SLA.0b013e3182a15bcc. doi:10.1097/SLA.0b013e3182a15bcc
[14]	韦皓棠, 陈利生. 粪便miRNA检测在结直肠癌诊断中的价值[J]. 结直肠肛门外科, 2017,23(5):565-569. DOI: 1674-0491(2017)05-0565-05. doi:1674-0491(2017)05-0565-05
[15]	Chang PY, Chen CC, Chang YS, et al. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection[J]. Oncotarget, 2016,7(9):10663-10675. DOI: 10.18632/oncotarget.7119. doi:10.18632/oncotarget.7119
[16]	Ahmed FE, Ahmed NC, Vos PW, et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: Ⅰ. Proof of principle[J]. Cancer Genomics Proteomics, 2013,10(3):93-113.
[17]	Liu J, Li H, Zheng B, et al. Competitive endogenous RNA (ce-RNA) regulation network of lncRNA-miRNA-mRNA in colorectal carcinogenesis[J]. Dig Dis Sci, 2019,64(7):1868-1877. DOI: 10.1007/s10620-019-05506-9. doi:10.1007/s10620-019-05506-9
[18]	Shuwen H, Qing Z, Yan Z, et al. Competitive endogenous RNA in colorectal cancer: a systematic review[J]. Gene, 2018,645:157-162. DOI: 10.1016/j.gene.2017.12.036. doi:S0378-1119(17)31089-2pmid:29273554
[19]	Xiao Z, Qu Z, Chen Z, et al. LncRNA HOTAIR is a prognostic biomarker for the proliferation and chemoresistance of colorectal cancer via miR-203a-3p-mediated Wnt/β-Catenin signaling pathway[J]. Cell Physiol Biochem, 2018,46(3):1275-1285. DOI: 10.1159/000489110. doi:10.1159/000489110
[20]	Ismail DM, Shaker OG, Kandeil MA, et al. Gene expression of the circulating long oncoding RNA H19 and HOTAIR in Egyptian colo-rectal cancer patients[J]. Genet Test Mol Biomarkers, 2019,23(9):671-680. DOI: 10.1089/gtmb.2019.0066. doi:10.1089/gtmb.2019.0066
[21]	Liu T, Zhang X, Gao S, et al. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer[J]. Oncotarget, 2016,7(51):85551-85563. DOI: 10.18632/oncotarget.13465. doi:10.18632/oncotarget.13465
[22]	Cheng Y, Wu J, Qin B, et al. CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis[J]. Biochem Biophys Res Commun, 2020,526(3):678-684. DOI: 10.1016/j.bbrc.2020.03.153. doi:10.1016/j.bbrc.2020.03.153
[23]	Shi Q, He Y, Zhang X, et al. Two novel long noncoding RNAs—RP11-296E3.2 and LEF1-AS1can—separately serve as diagnostic and prognostic bio-markers of metastasis in colorectal cancer[J]. Med Sci Monit, 2019,25:7042-7051. DOI: 10.12659/MSM.916314. doi:10.12659/MSM.916314
[24]	Liu H, Ye D, Chen A, et al. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers[J]. Clin Chem Lab Med, 2019,57(7):1073-1083. DOI: 10.1515/cclm-2019-0052. doi:10.1515/cclm-2019-0052
[25]	Xu W, Zhou G, Wang H, et al. Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer[J]. Int J Cancer, 2020,146(10):2901-2912. DOI: 10.1002/ijc.32747. doi:10.1002/ijc.32747
[26]	Gharib E, Nazemalhosseini-Mojarad E, Baghdar K, et al. Identification of a stool long non-coding RNAs panel as a potential biomarker for early detection of colorectal cancer[J]. J Clin Lab Anal, 2020,23:e23601. DOI: 10.1002/jcla.23601. doi:10.1002/jcla.23601
[27]	Hao S, Cong L, Qu R, et al. Emerging roles of circular RNAs in colorectal cancer[J]. Onco Targets Ther, 2019,12:4765-4777. DOI: 10.2147/OTT.S208235. doi:10.2147/OTT.S208235
[28]	Bach DH, Lee SK, Sood AK. Circular RNAs in cancer[J]. Mol Ther Nucleic Acids, 2019,16:118-129. DOI: 10.1016/j.omtn.2019.02.005. doi:10.1016/j.omtn.2019.02.005
[29]	Geng HH, Li R, Su YM, et al. The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression[J]. PLoS One, 2016,11(3):e0151753. DOI: 10.1371/journal.pone.0151753. doi:10.1371/journal.pone.0151753
[30]	Zhang P, Zuo Z, Shang W, et al. Identification of differentially expressed circular RNAs in human colorectal cancer[J]. Tumour Biol, 2017,39(3):1010428317694546. DOI: 10.1177/1010428317694546. doi:10.1177/1010428317694546
[31]	Hou J, Jiang W, Zhu L, et al. Circular RNAs and exosomes in cancer: a mysterious connection[J]. Clin Transl Oncol, 2018,20(9):1109-1116. DOI: 10.1007/s12094-018-1839-y. doi:10.1007/s12094-018-1839-ypmid:29536331
[32]	唐梦甜, 周菊梅, 廖前进, 等. 外泌体环状RNA在肿瘤微环境中的研究进展[J]. 生物化学与生物物理进展, 2021,48(2):135-146. DOI: 10.16476/j.pibb.2020.0191. doi:10.16476/j.pibb.2020.0191
[33]	Wang Y, Mo Y, Gong Z, et al. Circular RNAs in human cancer[J]. Mol Cancer, 2017,16(1):25. DOI: 10.1186/s12943-017-0598-7. doi:10.1186/s12943-017-0598-7
[34]	郝文静, 路丹. 环状RNA在肿瘤中的研究进展[J]. 肿瘤学杂志, 2019,25(3):243-246. DOI: 1671-170X(2019)03-0243-04. doi:1671-170X(2019)03-0243-04
[35]	Yang N, Xu B, Kong P, et al. Hsa_circ_0002320: a novel clinical biomarker for colorectal cancer prognosis[J]. Medicine (Baltimore), 2020,99(28):e21224. DOI: 10.1097/MD.0000000000021224. doi:10.1097/MD.0000000000021224
[36]	Zhang W, Yang S, Liu Y, et al. Hsa_circ_0007534 as a blood-based marker for the diagnosis of colorectal cancer and its prognostic value[J]. Int J Clin Exp Pathol, 2018,11(3):1399-1406.
[37]	Xing L, Xia M, Jiao X, et al. Hsa_circ_0004831 serves as a blood-based prognostic biomarker for colorectal cancer and its potentially circRNA-miRNA-mRNA regulatory network construction[J]. Cancer Cell Int, 2020,20(1):557. DOI: 10.1186/s12935-020-01651-8. doi:10.1186/s12935-020-01651-8
[38]	Lin J, Cai D, Li W, et al. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer[J]. Clin Biochem, 2019,74:60-68. DOI: 10.1016/j.clinbiochem.2019.10.012. doi:10.1016/j.clinbiochem.2019.10.012

Application of non-coding RNAs in early diagnosis of colorectal cancer

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References38

Related Articles15

Recommended Articles

Metrics

Comments

[1]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[2]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[3]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[4]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.
[5]	Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.Expression and clinical significance of ASB6 in colorectal cancer tissues[J]. Journal of International Oncology, 2023, 50(8): 470-474.
[6]	Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer[J]. Journal of International Oncology, 2023, 50(5): 268-273.
[7]	Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.Construction of postoperative prognosis model for patients with colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 157-163.
[8]	Xu Liangfu, Li Yuanfei.Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 186-190.
[9]	Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722.
[10]	Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer[J]. Journal of International Oncology, 2023, 50(11): 683-687.
[11]	Wang Xi, Wu Chuanqing.Research progress in reversing multidrug resistance in colorectal cancer[J]. Journal of International Oncology, 2023, 50(1): 42-46.
[12]	Gao Yizhao, Liu Yang, Liu Qiulong, Xing Jinliang.Application of circulating cell-free nucleic acid in clinical diagnosis and treatment of colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 555-559.
[13]	He Zhefeng, Wu Yiyang, Li Zhenjun, Ying Xiaojiang.Predictive value of inflammatory markers in colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 560-563.
[14]	Zhao Ying, Zhang Gehong.Study on the correlations between AGR, PLR and NLR changes and chemotherapy efficacy of metastatic colorectal cancer[J]. Journal of International Oncology, 2022, 49(8): 473-477.
[15]	Huang Mengpan, Wang Xuehong, Lu Yongfu.Mechanism of FOXA2 in colorectal cancer and its application in diagnosis and treatment[J]. Journal of International Oncology, 2022, 49(8): 490-493.